TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib (Q90602069)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 March 2020
edit
Language Label Description Also known as
English
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
scientific article published on 11 March 2020

    Statements

    TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit